Isethionate salt of a selective cdk4 inhibitor

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/519 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2532049

Disclosed are polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5- methyl-2~(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which is a selective cyclin-dependent kinase 4 (CDK4) inhibitor useful for treating inflammation and cell proliferative diseases such as cancer and restenosis.

L'invention concerne des polymorphes du sel d'iséthionate de 6-acétyl-8-cyclopentyl-5-méthyl-2-(5-pipérazin-1-yl-pyridin-2-ylamino)-8<I>H</I>-pyrido[2,3-d]pyrimidin-7-one, qui est un inhibiteur sélectif de la kinase 4 dépendante des cyclines, utile pour traiter l'inflammation et les maladies proliférantes cellulaires comme le cancer et la resténose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Isethionate salt of a selective cdk4 inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isethionate salt of a selective cdk4 inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isethionate salt of a selective cdk4 inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1562065

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.